Diagnostic examination performance by using microvascular leakage, cerebral blood volume, and blood flow derived from 3-T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in the differentiation of glioblastoma multiforme and brain metastasis

Neuroradiology

Volumn 53, Issue 5, 2011, Pages 319-330

  Server, Andrés ^a,b   Orheim, Tone E Døli ^c   Graff, Bjørn A ^a   Josefsen, Roger ^a   Kumar, Theresa ^a   Nakstad, Per H ^a,b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Brain neoplasms; DSC MRI; Magnetic resonance imaging; Perfusion

Indexed keywords

GADOLINIUM PENTETATE MEGLUMINE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; BRAIN METASTASIS; CANCER INFILTRATION; CLINICAL TRIAL; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; DYNAMIC SUSCEPTIBILITY WEIGHTED CONTRAST ENHANCED PERFUSION MAGNETIC RESONANCE IMAGING; EXTRAVASATION; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MICROVASCULAR LEAKAGE; MICROVASCULATURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION WEIGHTED IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; BLOOD VOLUME; BRAIN; BRAIN NEOPLASMS; CEREBROVASCULAR CIRCULATION; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLIOBLASTOMA; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MALE; MICROVESSELS; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 79955686010     PISSN: 00283940     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00234-010-0740-3     Document Type: Article

References (66)

1. Newton HB, Malkin MG (2008) Overview of brain tumor epidemiology. In: Newton HB, Jolesz FA (eds) Handbook of neuro-oncology neuroimaging. Elsevier, New York, pp 3-8
2. Nguyen TD, DeAngelis LM (2007) Brain metastases. Neurol Clin 25:1173-1192 (Pubitemid 47600579)
3. Landis SH, Murray T, Bolden S, Wingo PA (1999) Cancer statistics. CA Cancer J Clin 49:8-31
4. Atlas SW, Lavi E, Fisher PG (2002) Intraaxial brain tumors. In: Atlas SW (ed) Magnetic resonance imaging of the brain and spine. Lippincott Williams & Wilkins, Philadelphia, pp 677-685
5. Maluf FC, DeAngelis LM, Raizer JJ, Abrey LE (2002) High-grade gliomas in patients with prior systemic malignancies. Cancer 94:3219-3224 (Pubitemid 34670505)
6. Giese A, Bjerkvig R, Berens ME, Westphal M (2003) Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol 21:1624-1636 (Pubitemid 46594118)
7. Barnard RO, Geddes JF (1987) The incidence of multifocal cerebral gliomas. A histologic study of large hemisphere sections. Cancer 60:1519-1531
8. Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, Markesbery WR, Macdonald JS, Young B (1990) A randomized trial of surgery in the treatment of single metastases to the brain. N Eng J Med 322:494-500 (Pubitemid 20067825)
9. Giese A, Westphal M (2001) Treatment of malignant glioma: a problem beyond the margins of resection. J Cancer Res Clin Oncol 127:217-225
10. O'Neill BP, Buckner JC, Coffey RJ, Dinapoli RP, Shaw EG (1994) Brain metastatic lesions. Mayo Clin Proc 69:1062-1068 (Pubitemid 24346990)
11. Jain RK, di Tomaso E, Duda DG, Loeffler JS, Sorensen AG, Batchelor TT (2007) Angiogenesis in brain tumors. Nat Rev Neurosci 8:610-622
12. Fidler IJ, Yano S, Zhang RD, Fujimaki T, Bucana CD (2002) The seed and soil hypothesis: vascularisation and brain metastases. Lancet Oncol 3:53-57
13. Ocak I, Baluk P, Barrett T, McDonald DM, Choyke P (2007) The biologic basis of in vivo angiogenesis imaging. Front Biosci 12:3601-3616
14. Wesseling P, Ruiter DJ, Burger PC (1997) Angiogenesis in brain tumors; pathobiological and clinical aspects. J Neurooncol 32:253-265 (Pubitemid 27077976)
15. Jinnouchi T, Shibata S, Fukushima M, Mori K (1988) Ultrastructure of capillary permeability in human brain tumor - Part 6: metastatic brain tumor with brain edema. No Shinkei Geka 16(5 Suppl):563-568
16. Gagner JP, Law M, Fischer I, Newcomb EW, Zagzag D (2005) Angiogenesis in gliomas: imaging and experimental therapeutics. Brain Pathol 15:342-363 (Pubitemid 41677433)
17. Cha S (2004) Perfusion MR imaging of brain tumors. Top Magn Reson Imaging 15:279-289
18. Young RJ, Sills AK, Brem S, Knopp EA (2005) Neuroimaging of metastatic brain disease. Neurosurgery 57(5 Suppl):S10-S23
19. Sentürk S, Oǧuz KK, Cila A (2009) Dynamic contrast-enhanced susceptibility-weighted perfusion imaging of intracranial tumors: a study using a 3 T MR scanner. Diagn Interv Radiol 15:3-12
20. Law M, Cha S, Knopp EA, Johnson G, Arnett J, Litt AW (2002) High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 222:715-721 (Pubitemid 34215219)
21. Rollin N, Guyotat J, Streichenberger N, Honnorat J, Tran Minh VA, Cotton F (2006) Clinical relevance of diffusion and perfusion magnetic resonance imaging in assessing intra-axial brain tumors. Neuroradiology 48:150-159 (Pubitemid 43380227)
22. Chiang IC, Kuo YT, Lu CY, Yeung KW, Lin WC, Sheu FO, Liu GC (2004) Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings. Neuroradiology 46:619-627 (Pubitemid 39199519)
23. Hakyemez B, Erdogan C, Bolca N, Yildirim N, Gokalp G, Parlak M (2006) Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging. J Magn Reson Imaging 24:817-824 (Pubitemid 44549984)
24. Calli C, Kitis O, Yunten N, Yurtseven T, Islekel S, Akalin T (2006) Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors. Eur J Radiol 58:394-403 (Pubitemid 43729064)
25. Weber MA, Zoubaa S, Schlieter M, Jüttler E, Huttner HB, Geletneky K, Ittrich C, Lichy MP, Kroll A, Debus J, Giesel FL, Hartmann M, Essig M (2006) Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors. Neurology 66:1899-1906 (Pubitemid 44049824)
26. Lüdemann L, Grieger W, Wurm R, Wust P, Zimmer C (2005) Quantitative measurement of leakage volume and permeability in gliomas, meningiomas and brain metastases with dynamic contrast-enhanced MRI. Magn Reson Imaging 23:833-841 (Pubitemid 41579025)
27. Bulakbasi N, Kocaoglu M, Farzaliyev A, Tayfun C, Ucoz T, Somuncu I (2005) Assessment of diagnostic accuracy of perfusion MR imaging in primary and metastatic solitary malignant brain tumors. AJNR Am J Neuroradiol 26:2187-2199
28. Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK (2002) The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215-225 (Pubitemid 34212595)
29. Rosen BR, Belliveau JW, Vevea JM, Brady TJ (1990) Perfusion imaging with NMR contrast agents. Magn Reson Med 14:249-265 (Pubitemid 20248610)
30. Ostergaard L, Weisskoff RM, Chesler DA, Gyldensted C, Rosen BR (1996) High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: mathematical approach and statistical analysis. Magn Reson Med 36:715-725
31. Boxerman JL, Schmainda KM, Weisskoff RM (2006) Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol 27:859-867 (Pubitemid 44897737)
32. Emblem KE, Due-Tonnessen P, Hald JK, Bjornerud A (2009) Automatic vessel removal in gliomas from dynamic susceptibility contrast imaging. Magn Reson Med 61:1210-1217
33. Wetzel SG, Cha S, Johnson G, Lee P, Law M, Kasow DL, Pierce SD, Xue X (2002) Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study. Radiology 224:797-803 (Pubitemid 34919816)
34. Ranjan T, Abrey LE (2009) Current management of metastatic brain disease. Neurotherapeutics 6:598-603
35. Young GS, Setayesh K (2009) Spin-echo echo-planar perfusion MR imaging in the differential diagnosis of solitary enhancing brain lesions: distinguishing solitary metastases from primary glioma. AJNR Am J Neuroradiol 30:575-577
36. Mukundan S, Holder C, Olson JJ (2008) Neuroradiological assessment of newly diagnosed glioblastoma. J Neurooncol 89:259-269
37. Cha S (2006) Update on brain tumor imaging: from anatomy to physiology. AJNR Am J Neuroradiol 27:475-487
38. Provenzale JM, Wang GR, Brenner T, Petrella JR, Sorensen AG (2002) Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. AJR Am J Roentgenol 178:711-716 (Pubitemid 34178155)
39. Law M, Yang S, Babb JS, Knopp EA, Golfinos JG, Zagzag D, Johnson G (2004) Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 25:746-755 (Pubitemid 38657655)
40. Roberts HC, Dillon WP (2000) MR imaging of brain tumors: toward physiologic imaging. AJNR Am J Neuroradiol 21:1570-1571
41. Roberts HC, Roberts TP, Ley S, Dillon WP, Brasch RC (2002) Quantitative estimation of microvascular permeability in human brain tumors: correlation of dynamic Gd-DTPA-enhanced MR imaging with histopathologic grading. Acad Radiol 9(Suppl 1):S151-S155 (Pubitemid 34441470)
42. Jain R, Elika SK, Scarpace L, Rock JP, Gutierrez J, Patel SC, Ewing J, Mikkelsen T (2008) Quantitative estimation of permeability surface-area product in astroglial brain tumors using perfusion CT and correlation with histopathologic grade. AJNR Am J Neuroradiol 29:694-700 (Pubitemid 351571548)
43. Tate MC, Aghi MK (2009) Biology of angiogenesis and invasion in glioma. Neurotherapeutics 6:447-457
44. Folkman J (2006) Angiogenesis. Annu Rev Med 57:1-18
45. Bullitt E, Reardon DA, Smith JK (2007) A review of micro- and macrovascular analysis in the assessment of tumor-associated vasculature as visualized by MR. Neuroimage 37(Suppl 1):S116-119
46. Carbonell WS, Ansorge O, Sibson N, Muschel R (2009) The vascular basement membrane as "soil" in brain metastases. PLoS ONE 4:e5857
47. Hasegawa H, Ushio Y, Hayakawa T, Yamada K, Mogami H (1983) Changes of the blood-brain barrier in experimental metastatic brain tumors. J Neurosurg 59:304-310 (Pubitemid 13029212)
48. Zhang M, Olsson Y (1997) Hematogenous metastases of the human brain - characteristics of peritumoral brain changes: a review. J Neurooncol 35:81-89 (Pubitemid 27361849)
49. Bertossi M, Virgintino D, Maiorano E, Occhiogrosso M, Roncali L (1997) Ultrastructural and morphometric investigation of human brain capillaries in normal and peritumoral tissues. Ultrastruct Pathol 21:41-49 (Pubitemid 27099728)
50. Stummer W (2007) Mechanisms of tumor-related brain edema. Neurosurg Focus 15(22):E8
51. Engelhorn T, Savaskan NE, Schwarz MA, Kreutzer J, Meyer EP, Hahnen E, Ganslandt O, Dörfler A, Nimsky C, Buchfelder M, Eyüpoglu IY (2009) Cellular characterization of the peritumoral edema zone in malignant brain tumors. Cancer Sci 100:1856-1862
52. Long DM (1979) Capillary ultrastructure in human metastatic brain tumors. J Neurosurg 51:53-58
53. Stewart PA, Hayakawa K, Hayakawa E, Farrell CL, Del Maestro RF (1985) A quantitative study of blood-brain barrier permeability ultrastructure in a new rat glioma model. Acta Neuropathol 67:96-102 (Pubitemid 15021216)
54. Shin JH, Lee HK, Kwun BD, Kim JS, Kang W, Choi CG, Suh DC (2002) Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results. AJR Am J Roentgenol 179:783-789 (Pubitemid 34919600)
55. Gerstner ER, Sorensen AG, Jain RK, Batchelor TT (2008) Advances in neuroimaging techniques for the evaluation of tumor growth, vascular permeability, and angiogenesis in gliomas. Curr Opin Neurol 21:728-735
56. Miller JC, Pien HH, Sahani D, Sorensen AG, Thrall JH (2005) Imaging angiogenesis: applications and potential for drug development. J Natl Cancer Inst 97:172-187 (Pubitemid 40277367)
57. Ostergaard L, Hochberg FH, Rabinov JD, Sorensen AG, Lev M, Kim L, Weisskoff RM, Gonzalez RG, Gyldensted C, Rosen BR (1999) Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors. J Neurosurg 90:300-305 (Pubitemid 29068132)
58. McDonald DM, Choyke PL (2003) Imaging of angiogenesis: from microscope to clinic. Nat Med 9:713-725 (Pubitemid 36749220)
59. Bhujwalla ZM, Artemov D, Natarajan K, Solaiyappan M, Kollars P, Kristjansen PE (2003) Reduction of vascular and permeable regions in solid tumors detected by macromolecular contrast magnetic resonance imaging after treatment with antiangiogenic agent TNP-470. Clin Cancer Res 9:355-362 (Pubitemid 36109752)
60. Chernov MF, Kubo O, Hayashi M, Izawa M, Maruyama T, Usukura M, Ono Y, Hori T, Takakura K (2005) Proton MRS of the peritumoral brain. J Neurol Sci 228:137-142 (Pubitemid 40202958)
61. Lüdemann L, Warmuth C, Plotkin M, Förschler A, Gutberlet M, Wust P, Amthauer H (2009) Brain tumor perfusion: comparison of dynamic contrast enhanced magnetic resonance imaging using T1, T2, and T2* contrast, pulsed arterial spin labelling, and H2(15)O positron emission tomography. Eur J Radiol 70:465-474
62. Paulson ES, Schmainda KM (2008) Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors. Radiology 249:601-613
63. Levin JM, Wald LL, Kaufman MJ, Ross MH, Maas LC, Renshaw PF (1998) T1 effects in sequential dynamic susceptibility contrast experiments. J Magn Reson 130:292-295 (Pubitemid 128451240)
64. Runge VM, Kirsch JE, Wells JW, Dunworth JN, Hilaire L, Woolfolk CE (1994) Repeat cerebral blood volume assessment with first-pass MR imaging. J Magn Reson Imaging 4:457-461
65. Levin JM, Wald LL, Kaufman MJ, Ross MH, Maas LC, Renshaw PF (1995) Sequential dynamic susceptibility contrast MR experiments in human brain: residual contrast agent effect, steady state, and hemodynamic perturbation. Magn Reson Med 34:655-663
66. Barajas RF, Chang JS, Segal MR, Parsa AT, McDermott MW, Berger MS, Cha S (2009) Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility- weighted contrast-enhanced perfusion MR imaging. Radiology 253:486-496